BCRX vs HCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BCRX

42.9
AI Score
VS
BCRX Wins

HCM

36.7
AI Score

Investment Advisor Scores

BCRX

43score
Recommendation
HOLD

HCM

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BCRX HCM Winner
Forward P/E 13.0378 277.7778 BCRX
PEG Ratio 9.3878 0 Tie
Revenue Growth 13.1% 0.2% BCRX
Earnings Growth 133.3% -96.5% BCRX
Tradestie Score 42.9/100 36.7/100 BCRX
Profit Margin -37.4% 3.3% HCM
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY BCRX

Relative Price Performance (Last 90 Days)

BCRX 1M: -3.5% · 3M: -20.3% HCM 1M: +11.0% · 3M: +22.7%

Current Technical Phase

BCRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.3%), weak momentum, RSI 44

RSI (14): 44.1 · Price: $7.77

HCM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.7% over 20 days), RSI 59

RSI (14): 59.2 · Price: $14.97

Fundamentals Snapshot

Metric BCRX HCM
Market Cap — —
Forward P/E 9.0 58.2
Trailing P/E — 153.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.8% 0.1%
Operating Margin 0.4% 0.0%
EPS -1.28 0.10
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.